Premium
[P3–018]: A SUMMARY OF BASELINE EFFICACY CHARACTERISTICS FROM THE MINDSET STUDY: A GLOBAL PHASE 3 STUDY OF INTEPIRDINE (RVT‐101) IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER's DISEASE
Author(s) -
Lombardo Ilise,
Ramaswamy Geetha,
Fogel Ilan,
Mo Yi,
Friedhoff Lawrence,
Bruinsma Bote
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.1831
Subject(s) - donepezil , mindset , placebo , memantine , clinical trial , medicine , dementia , psychology , randomized controlled trial , alzheimer's disease , neuropsychology , clinical endpoint , psychiatry , physical therapy , disease , cognition , pathology , alternative medicine , philosophy , epistemology